Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Verhamme

Showing results (281-290 of 321) with videos related to

Pageof 33
Sort By:
Gastroenterology|March 5, 2026
Cardiovascular Outcomes following Major Gastrointestinal Bleeding in Patients with Pre-existing Cardiovascular Disease: the INTERBLEED International Prospective Cohort StudyNauzer Forbes, John W Eikelboom, Qilong Yi, et al.
Circulation|September 13, 2019
Bleeding and New Cancer Diagnosis in Patients With AtherosclerosisJohn W Eikelboom, Stuart J Connolly, Jacqueline Bosch, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
The New England Journal of Medicine|March 21, 2017
Rivaroxaban or Aspirin for Extended Treatment of Venous ThromboembolismJeffrey I Weitz, Anthonie W A Lensing, Martin H Prins, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The New England Journal of Medicine|July 12, 2017
Idarucizumab for Dabigatran Reversal - Full Cohort AnalysisCharles V Pollack, Paul A Reilly, Joanne van Ryn, et al.
Nature Cardiovascular Research|December 16, 2025
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Kidney International Reports|November 14, 2017
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic BiomarkerClaudia Pontillo, Zhen-Yu Zhang, Joost P Schanstra, et al.
Thrombosis and Haemostasis|July 31, 2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer StudyNoémie Kraaijpoel, Marcello Di Nisio, Frits I Mulder, et al.
Pageof 33

Showing results (281-290 of 321) with videos related to

Sort By:
Pageof 33
Gastroenterology|March 5, 2026
Cardiovascular Outcomes following Major Gastrointestinal Bleeding in Patients with Pre-existing Cardiovascular Disease: the INTERBLEED International Prospective Cohort StudyNauzer Forbes, John W Eikelboom, Qilong Yi, et al.
Circulation|September 13, 2019
Bleeding and New Cancer Diagnosis in Patients With AtherosclerosisJohn W Eikelboom, Stuart J Connolly, Jacqueline Bosch, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
The New England Journal of Medicine|March 21, 2017
Rivaroxaban or Aspirin for Extended Treatment of Venous ThromboembolismJeffrey I Weitz, Anthonie W A Lensing, Martin H Prins, et al.
Trials|November 28, 2020
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trialTimothy Devos, Tatjana Geukens, Alexander Schauwvlieghe, et al.
The New England Journal of Medicine|July 12, 2017
Idarucizumab for Dabigatran Reversal - Full Cohort AnalysisCharles V Pollack, Paul A Reilly, Joanne van Ryn, et al.
Nature Cardiovascular Research|December 16, 2025
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
Thrombosis and Haemostasis|September 17, 2021
Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: Rationale and Design of the API-CAT StudyIsabelle Mahé, Giancarlo Agnelli, Cihan Ay, et al.
Kidney International Reports|November 14, 2017
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic BiomarkerClaudia Pontillo, Zhen-Yu Zhang, Joost P Schanstra, et al.
Thrombosis and Haemostasis|July 31, 2018
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer StudyNoémie Kraaijpoel, Marcello Di Nisio, Frits I Mulder, et al.
Pageof 33